Q4 2024 Outset Medical Inc Earnings Call Transcript

Feb 19, 2025 / 10:00 PM GMT

Release Date Price: $14.1 (+3.52%)

Transcript 10-K8-K

Key Points

Positve

Outset Medical Inc (OM) reported sequential revenue growth and a notable increase in gross margins for Q4 2024.
The company achieved a significant strengthening of its balance sheet with a $172.7 million equity financing, reducing outstanding debt from $200 million to $100 million.
Recurring revenue grew 13% sequentially and 17% year-over-year, driven by strong utilization across nearly 6,000 Tableau consoles.
The company received notification from the FDA that the warning letter from July 2023 had been officially closed, following a successful inspection.
Outset Medical Inc (OM) has a strong pipeline with 70% of top opportunities in late stages of the sales process, indicating potential for future growth.

Negative

Revenue for the full year 2024 was $113.7 million, below the original plan for the year.
Product revenue declined 8% year-over-year due to lower console sales.
The company is still facing challenges with under absorption of manufacturing overhead, affecting gross margins.
Operating expenses, although reduced, still amounted to $26.6 million for Q4 2024.
The company anticipates using under $50 million of cash in 2025, which, while reduced, still indicates significant cash outflow.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

OM.OQ - Outset Medical Inc
Q4 2024 Outset Medical Inc Earnings Call
Feb 19, 2025 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to the Outseted 4th quarter 2024 earnings conference call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there'll be a question and answer session. To ask a question during the session, you'll need to press 11 on your telephone. You will then hear an automated message advising your hand is raised to withdraw your question, please press 11 again. Please be advised that this conference is being recorded. I would not like to end the conference over to your speaker today, Jim Mazzola, head of investor relations, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.